NYSE:AVNS - Avanos Medical Stock Price, News & Analysis

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical Inc (NYSE:AVNS) posted its earnings results on Tuesday, August, 6th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.03. The company earned $172.20 million during the quarter, compared to analysts' expectations of $172.02 million. Avanos Medical had a negative net margin of 3.92% and a positive return on equity of 4.18%. Avanos Medical's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.20 earnings per share. View Avanos Medical's Earnings History.

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Avanos Medical.

Avanos Medical updated its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.23.

6 brokerages have issued 1-year price objectives for Avanos Medical's stock. Their forecasts range from $45.00 to $69.00. On average, they anticipate Avanos Medical's share price to reach $54.80 in the next year. This suggests a possible upside of 49.6% from the stock's current price. View Analyst Price Targets for Avanos Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

Media headlines about AVNS stock have been trending negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avanos Medical earned a news sentiment score of -2.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Avanos Medical.

Avanos Medical saw a decrease in short interest in the month of August. As of August 31st, there was short interest totalling 2,579,400 shares, a decrease of 6.7% from the July 31st total of 2,763,300 shares. Based on an average trading volume of 286,600 shares, the short-interest ratio is presently 9.0 days. Currently, 5.5% of the company's stock are short sold. View Avanos Medical's Current Options Chain.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Rewalk Robotics (RWLK), Histogenics (HSGX), Precision Therapeutics (POAI), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL) and Wound Management Technologies (WNDM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Honeywell International (HON), CVS Health (CVS), AlarmCom (ALRM), IHS Markit (INFO), Workday (WDAY), Baxter International (BAX), Kimberly Clark (KMB), Nike (NKE), Veeva Systems (VEEV) and Westinghouse Air Brake Technologies (WAB).

Avanos Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.46%), BlackRock Inc. (11.46%), Price T Rowe Associates Inc. MD (10.32%), Vanguard Group Inc. (9.44%), Victory Capital Management Inc. (4.80%) and Paradice Investment Management LLC (4.19%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Chicago Equity Partners LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp, Vanguard Group Inc., Morgan Stanley, Price T Rowe Associates Inc. MD and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Avanos Medical.

AVNS stock was bought by a variety of institutional investors in the last quarter, including RGM Capital LLC, Paradice Investment Management LLC, Invesco Ltd., Nuveen Asset Management LLC, Marshall Wace LLP, Confluence Investment Management LLC, Victory Capital Management Inc. and Northern Trust Corp. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $36.64.

Avanos Medical has a market capitalization of $1.75 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

The official website for Avanos Medical is http://www.halyardhealth.com/.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]